Hormones &
Contraceptives

Hormones & Contraceptive Medicine Supply for Hospitals & International Buyers

Hormonal and endocrine medicines cover a wide spectrum of clinical need, from contraception and menopause management to thyroid disorders, adrenal insufficiency, fertility treatment and diabetes. Euro Biom works with NHS hospitals, women's health clinics, endocrinology departments and international healthcare buyers to supply these medicines reliably, including products that have experienced shortage or that are unavailable through local distribution channels in GCC and African markets.

Thyroid medicines are among the most widely prescribed long-term treatments globally. We supply levothyroxine in all available strengths, including the branded formulations to which patients in the UK are stabilised on clinical grounds where brand switching has caused adverse effects. Liothyronine (T3) for combined thyroid replacement is also available. For hyperthyroidism, we supply carbimazole and propylthiouracil in the tablet strengths used in UK clinical practice.

Adrenal medicines are critical for patients with Addison's disease, congenital adrenal hyperplasia and other conditions requiring corticosteroid replacement. Our range includes hydrocortisone tablets and injection (which has been subject to significant UK shortage in recent years), fludrocortisone for mineralocorticoid replacement, prednisolone and dexamethasone. We maintain stock of hydrocortisone across multiple formats and can supply urgently where hospitals face local shortages.

Contraceptives, HRT and Fertility Medicines

Our contraceptive portfolio covers combined oral contraceptives across all major brands and formulations, progestogen-only pills (including desogestrel), emergency contraception (levonorgestrel and ulipristal acetate), injectable contraceptives (medroxyprogesterone acetate, norethisterone enantate) and hormone-releasing implants. These products are supplied to pharmacies, family planning services and international buyers requiring UK-sourced branded products.

HRT experienced well-documented supply shortages in the UK from 2019 onwards, creating demand from international buyers seeking alternative sources of estradiol and progesterone preparations. Our HRT range includes estradiol oral tablets, transdermal patches (multiple strengths and brands), estradiol gel and spray, micronised progesterone (Utrogestan), tibolone and combined estradiol-progestogen tablet preparations. We hold stock of multiple brands and can fulfil orders for patients stabilised on specific products.

Fertility medicines require careful sourcing and often involve cold-chain biologics. We supply clomifene citrate for ovulation induction, gonadotrophins including recombinant FSH (follitropin) and LH preparations, human chorionic gonadotrophin (hCG), GnRH analogues used for pituitary downregulation (buserelin, leuprorelin, triptorelin) and progesterone vaginal pessaries (Cyclogest) for luteal phase support. These medicines are frequently required by fertility units in GCC countries that cannot source them locally.

The endocrine category overlaps with diabetes management through insulin analogues and newer glucose-lowering agents. We supply insulin analogues including glargine, detemir, aspart and lispro in pen and vial presentations. GLP-1 receptor agonists including semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity) and liraglutide (Victoza, Saxenda) have experienced severe global supply constraints, and Euro Biom works to source these through licensed UK channels. SGLT2 inhibitors and other oral diabetes medicines are also available.

For GCC and African buyers, the demand for UK-sourced hormonal medicines is driven by several factors: HRT shortage alternatives, thyroid brand sensitivity requiring specific UK-manufactured levothyroxine formulations, fertility medicine sourcing for specialist clinics and the need for GDP-compliant cold-chain logistics for insulin analogues and GLP-1 biologics. Euro Biom supplies under our MHRA Wholesale Dealer Authorisation, with export documentation accepted by regulatory authorities across the UAE, Saudi Arabia, Qatar, Kuwait, Bahrain, Oman and Africa.